Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $4.27 is 81.70% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 4.35||$ 7.611|
|Low:||$ 4.18||$ 2.35|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using our proprietary, bioresorbable hydrogel platform technology. We use this technology to tailor duration and amount of delivery of a range of therapeutic agents of varying duration in our product candidates. We are pursuing three overall strategic goals: · To make prescription eye drops obsolete; · To make immediate release, back-of-the-eye injections obsolete; and · To extend our hydrogel platform technology for use beyond the eye to other areas of the body. We currently incorporate therapeutic agents that have previously received regulatory approval, including small molecules and proteins, into our hydrogel technology with the goal of providing local programmed-released delivery of drug to the eye. ... More ...
Nasdaq Official Price
Jun. 26, 2019
Jun. 26, 2019